Cancer Treatment Ctr-America is categorized under in Tulsa, OK and active since 1991.
Cancer Treatment Ctr-America was established in 1991, and today employs 1 to 4, earning $100.000.000 to $499.999.999 per year. This is a business, which does work in the B2C market, and is classified as a , under code number 6223100 by the NAICS.
If you are seeking more information, feel free to contact Steven Mackin, Chief Executive Officer at the company’s branch by writing to 10109 East 79th St, Tulsa, Oklahoma OK 74133 or by phoning (918) 286-5000. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Cancer Treatment Ctr-America |
| Contact Person: | Steven Mackin, Chief Executive Officer |
| Address: | 10109 East 79th St, Tulsa, Oklahoma 74133 |
| Phone Number: | (918) 286-5000 |
| Website Address: | cancercenter.com |
| Annual Revenue (USD): | $100.000.000 to $499.999.999 |
| Founded: | 1991 |
| Location Type: | Branch |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | |
| SIC Code: | 8069 |
| NAICS Code: | 6223100 |
| Share This Business: |
Cancer Treatment Ctr-America was started in 1991 to provide professional under the SIC code 8069 and NAICS code 6223100. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000.000 to $499.999.999 per annum.
Feel free to contact Steven Mackin, Chief Executive Officer for inquiries that concern Cancer Treatment Ctr-America by calling the company number (918) 286-5000, as your correspondence is most welcome. Additionally, the physical location of the branch of Cancer Treatment Ctr-America can be found at the coordinates 36.050145,-95.865323 as well as the street address 10109 East 79th St in Tulsa, Oklahoma 74133.
For its online presence, you may visit Cancer Treatment Ctr-America’s website at cancercenter.com and engage with its social media outlets through on Twitter and on Facebook.